St. John's Wort Cream for Eczema: Reading a Small Split-Body Trial Alongside Sun-Safety Concerns

St. John's wort is often recognized as an oral herbal supplement. A different question concerns a specific cream studied for eczema. For someone who exercises outdoors, the evidence needs two separate readings: whether that formulation improved eczema in a controlled comparison, and what is known about safety around sunlight and other medicines.

One person supplied both treatment areas

The 2003 trial's publisher summary and PubMed record describes 21 people with mild-to-moderate atopic dermatitis, of whom 18 completed four weeks. A cream containing Hypericum extract standardized to 1.5% hyperforin was compared with its vehicle. Random assignment determined which body side received each preparation; both were applied twice daily. The main outcome was a modified SCORAD lesion assessment.

Both sides improved. The active cream was superior on the lesion measure at days 7, 14 and 28, with p<0.05. Staphylococcus aureus colonization decreased with both preparations; the additional antibacterial signal had p=0.064 and did not meet the conventional 0.05 threshold. Both preparations received favorable short-term tolerance ratings. This was not a comparison against a prescribed steroid.

What a split-body design helps answer

Comparing two areas on the same person reduces some differences that would arise between unrelated participants. Daily environment and many personal characteristics are shared. It is still a small study with a short observation window. A result on selected lesions does not automatically describe whole-body control, sleep, future flares or the ability to tolerate a product during months of training.

The bacterial endpoint deserves particular care. Improvement in a clinical score and change in skin colonization are different findings. A cream should not be presented as an infection treatment because an ingredient has laboratory antibacterial activity or because a clinical study reported a nonsignificant trend. Our article about crusting and antibiotic decisions discusses why a changing rash needs clinical context.

Sun exposure and oral interactions are separate issues

NCCIH warns that applying St. John's wort to skin can cause severe skin reactions after sun exposure. It also describes important medicine interactions with oral use, including effects on several prescription medicines. Do not assume that an oral interaction has the same magnitude with a particular cream; equally, do not turn a cream trial into a reason to take the herb by mouth.

For an outdoor routine, show the exact preparation to a pharmacist or clinician before experimenting. Discuss the area of use, planned sun exposure, other skin products and any medication or supplement taken orally. Our photosensitivity guide can help structure that discussion. A favorable tolerance rating in a brief trial is not permission to ignore a current safety caution.

Keep an experimental product separate from established care

Ask which outcome you want to change and how you would judge it. If the concern is persistent inflammation, repeated infection or sleep disruption, reviewing the diagnosis and treatment plan is more useful than assuming every botanical cream is a substitute for prescribed care. Avoid stacking several new products, which makes a reaction or an apparent benefit harder to interpret.

AAD emphasizes gentle skin care and individualized treatment. Our herbal-treatment evidence guide explains why plant preparations differ. A larger controlled study with meaningful follow-up could strengthen this evidence; the current small trial cannot supply the long-term and product-specific answers that a personal decision requires.

Compare the related evidence

The licorice-gel trial raises a related question about extract concentration, symptom scores and the limits of a short observation period.

Prepared by the Dr. Arsy editorial team. Sources checked November 9, 2026. Educational information supports a conversation with a qualified clinician and does not diagnose or prescribe. The AI-created sports product image is an editorial illustration, not a patient photograph or clinical result.